Trump is rambling on re all sorts of topics. This one hitting the after hours price of weight loss drug makers:
- Think the “fat-loss drugs” will be a lot lower in price
Trump is rambling on re all sorts of topics. This one hitting the after hours price of weight loss drug makers:
Most Popular
Sponsored
Enagás buys 31.5% of Teréga for €573M, boosting regulated assets. Sells 40% of renewables for €48M. Stable returns ahead.
Boeing's revenue growth slows to 10.8% YoY. Analysts hold estimates, but past misses loom. Peers show mixed results.
Bitcoin's 40% drop may be just the start; history shows deeper falls & potential for 77%+ losses.
MTH faces revenue declines, but its stock's up 13.2% pre-earnings. Analysts see $79.22 target.
Nike's -27.8% YTD return, hurt by tariffs & competition. Gross margin down 2.5%. Avoid.
LBRT earnings loom. Last qtr revenue up 10.1%, but sector's down 3.6%. LBRT itself fell 9.6%.
S&P 500's CAPE ratio at 39.5 signals potential drawdown despite record highs. Consumer sentiment low.
Sponsored
Must Read